Premium
Calcipotriol for erythema annulare centrifugum
Author(s) -
Gniadecki R.
Publication year - 2002
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1046/j.0007-0963.2001.04572.x
Subject(s) - medicine , dermatology , clearance , calcipotriol , erythema , psoralen , etiology , granuloma annulare , psoriasis , dna , genetics , biology , urology
Erythema annulare centrifugum (EAC) is an uncommon inflammatory skin disease of unknown aetiology. No therapy is currently available. We describe a 73‐year‐old woman with a 3‐year history of EAC that was resistant to topical and systemic glucocorticoids, antifungals, and psoralen plus ultraviolet A treatment. After 3 months of treatment with topical calcipotriol the lesions cleared completely and did not recur during a 6‐month follow‐up period. Vitamin D analogues may be of value in the therapy of EAC.